Regeneron teams up with Swiss drugmaker to boost production of Covid-19 treatment
August 20, 2020 at 15:46 PM EDT
The agreement comes as Regeneron is in the midst of clinical trials to determine if its antibody cocktail is a viable treatment or prevention for Covid-19. REGN-COV2 must prove to be safe and effective before Regeneron and Roche could begin distributing the product.
